title: Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?
authors.affiliation: Hématologie Biologique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Kosmider
authors.affiliation: Hématologie Biologique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), France.
authors.forename: Marie
authors.initials: M
authors.lastname: Passet
authors.affiliation: University of Florence, AOU Careggi, Hematology, Italy.
authors.forename: Valeria
authors.initials: V
authors.lastname: Santini
authors.affiliation: University Hospital Carl Gustav Carus Dresden, Germany.
authors.forename: Uwe
authors.initials: U
authors.lastname: Platzbecker
authors.affiliation: Hématologie Biologique, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris (AP-HP), France.
authors.forename: Valérie
authors.initials: V
authors.lastname: Andrieu
authors.affiliation: Università Cattolica Sacro Cuore, Roma, Italy.
authors.forename: Gina
authors.initials: G
authors.lastname: Zini
authors.affiliation: IUCT, Oncopole, Toulouse, France.
authors.forename: Odile
authors.initials: O
authors.lastname: Beyne-Rauzy
authors.affiliation: Hôpital de Brabois, Nancy, France.
authors.forename: Agnès
authors.initials: A
authors.lastname: Guerci
authors.affiliation: Universita degli Studi di Firenze, Italy.
authors.forename: Erico
authors.initials: E
authors.lastname: Masala
authors.affiliation: IRCCS AOU San Martino-IST di Genova, Italy.
authors.forename: Enrico
authors.initials: E
authors.lastname: Balleari
authors.affiliation: University Hospital Carl Gustav Carus Dresden, Germany.
authors.forename: Ekaterina
authors.initials: E
authors.lastname: Bulycheva
authors.affiliation: Hôpital Cochin, Service d'hématologie, Paris, France.
authors.forename: François
authors.initials: F
authors.lastname: Dreyfus
authors.affiliation: Hôpital Saint Louis, Service d'hématologie séniors, Paris, France.
authors.forename: Pierre
authors.initials: P
authors.lastname: Fenaux
authors.affiliation: Hématologie Biologique, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), France.
authors.forename: Michaela
authors.initials: M
authors.lastname: Fontenay
authors.affiliation: CHU de Grenoble Alpes, Université Grenoble Alpes, Clinique Universitaire d'hématologie, Grenoble, France spark@chu-grenoble.fr.
authors.forename: Sophie
authors.initials: S
authors.lastname: Park
mesh_terms: D018572:Disease-Free Survival; D005260:Female; D006397:Hematinics / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009154:Mutation; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000235:genetics / Q000401:mortality; D012307:Risk Factors; D015996:Survival Rate
chemical_list: D006397:Hematinics
keywords: cytogenetics and molecular genetics; myelodysplastic syndromes; red cells